WENDI ELLEN AMES
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family VIDOR, TX NPI 1033725718
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TX Supernus Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$2,141.43
- Category: General Payments
- Program years: PY2021–2024
- Record count: 92
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,601.32 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,601.32 | 67 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $239.78 | 4 |
| ABBVIE INC. | $198.08 | 12 |
| Neurelis, Inc. | $166.00 | 4 |
| UCB, Inc. | $140.40 | 4 |
| PFIZER INC. | $97.02 | 5 |
| EISAI INC. | $93.13 | 5 |
| Lundbeck LLC | $82.64 | 5 |
| Biogen, Inc. | $74.75 | 4 |
| JAZZ PHARMACEUTICALS INC. | $74.64 | 4 |
| Incyte Corporation | $64.47 | 3 |
| Acerta Pharma LLC | $57.23 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $49.63 | 2 |
| Teva Pharmaceuticals USA, Inc. | $42.63 | 3 |
| Kyowa Kirin, Inc. | $38.96 | 2 |
| Neurocrine BioSciences, Inc. | $32.96 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.39 | 1 |
| Mallinckrodt Hospital Products Inc. | $26.62 | 1 |
| Alexion Pharmaceuticals, Inc. | $25.33 | 1 |
| ARGENX US, INC. | $23.97 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $16.41 | 1 |
| Amneal Pharmaceuticals LLC | $15.09 | 1 |
| Daiichi Sankyo Inc. | $13.19 | 1 |
By program year
Records — PY2024 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.